Titlebook: Medical Imaging Contrast Agents: A Clinical Manual; Sukru Mehmet Erturk,Pablo R. Ros,Suzan Saylisoy Book 2021 Springer Nature Switzerland

只有

Perfusion CT and MR Imaging of the Brain, interventional guiding, and also treatment monitoring procedures of brain lesions. In recent years, perfusion imaging techniques have come to the forefront in stroke, neurodegenerative diseases, and tumor characterization.

exigent

Gastrointestinal Iodinated Contrast Agents,ith intravenous contrast in order to evaluate the small bowel in patients with Crohn’s disease, small bowel polyps or malignancy, vascular lesions of the small bowel wall, and gastrointestinal bleeding and extraenteric structures. This chapter summarizes physical properties, clinical uses, and adverse effects of oral contrast agents.

Extricate

Basic Properties of Ultrasound Contrast Agents,t of the lesion compared to the adjacent tissue. Special care was taken to discuss artefacts, their appearance and how to avoid them. UCA application, specific imaging techniques (e.g. CEUS-guided interventions, paediatric patients and newborns, extravascular-intracavitary use and quantification) and safety issues are also discussed in depth.

ASSAY

Contrast-Enhanced CT Scanning of the Liver and Pancreas,n that you are focusing on, because various features may be highlighted depending on the phase. Obtaining optimal dynamic CT images is one of the most important processes required to diagnose hepatic and pancreatic disease correctly.

palette

Commodious

boisterous

Adverse Reactions to Iodinated Contrast Agents, administration of ICA) may reduce the frequency of urticaria, angioedema, and respiratory symptoms. Mild reactions generally do not require specific treatment. Moderate and severe reactions manifest serious degrees of reactions requiring immediate management.

細查

Fsh238

搖曳的微光

Peripheral Contrast-Enhanced CT and MR Angiography, can hinder stenosis assessment on CT angiography. On the other hand, MR angiography has some drawbacks, such as not being able to evaluate calcification and toxicity from gadolinium-based contrast agents (GBCAs).